Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Lantus Articles

Lantus and Levemir: What's the Difference?
An Interview With Robert Cuddihy, MD, of Sanofi US
The First 25
Hospitals Moving Toward Greater Use of Insulin Pens
Protecting Yourself Against Insulin Shock in the First Trimester of Pregnancy With Diabetes
Profiles in Type 1: Dr. Jonathan Beach
Profiles in Type 1: Gene Thornton
Ryan Shafer: Pro Bowler With Type 1
Profiles in Type 1: Kent David
Living With Type 1 Diabetes Since 1931
Lantus Archives
Browse the Lantus Archives
Subscribe to the Medications RSS Feed
Print | Email | Share | Comments (0)

Insulin Detemir Beats NPH at Blood Glucose Control


Jul 1, 2004

Insulin detemir.

Blood glucose control with detemir, a long-acting insulin analog, is better than NPH insulin.

Insulin detemir, manufactured by Novo Nordisk and expected to be a competitor with the long-acting insulin glargine (Lantus), was studied in 408 people with type 1 diabetes for 16 weeks. Insulin detemir was administered twice daily using two different regimens: either before breakfast and at bedtime, or at 12-hour intervals.

NPH insulin was administered before breakfast and at bedtime.

In all treatment groups rapid-acting insulin was administered at mealtimes.

With both detemir-treated groups, fasting blood glucose (BG) improved. The 12-hour-interval group’s BGs were 27 mg/dl lower than the NPH-treated group’s, and the before-breakfast and bedtime-determir group was 40 mg/dl lower than the NPH-treated group.

The risk of minor hypoglycemia was lower in both detemir-treated groups.

—Diabetes Care, May 2004

Categories: Blood Glucose, Diabetes, Diabetes, Insulin, Lantus, Low Blood Sugar, Novo Nordisk, Type 1 Issues

Donate to Diabetes Health

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Jul 1, 2004

©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.